# OnCo record ng-350a (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/ng-350a/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "ng-350a" ;
  schema:name "NG-350A"@en ;
  schema:alternateName "NG350A"@en ;
  schema:description "NG-350A is an experimental cancer-killing virus from Akamis Bio, in phase 1 trials for locally advanced rectal cancer."@en ;
  schema:url <https://onco.cc/drugs/ng-350a/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.akamisbio.com/science-pipeline/pipeline/>, <https://www.akamisbio.com/news/akamis-bio-announces-60-million-in-funding-linked-to-series-a-prime-financing-and-new-strategic-partnership/>, <https://clinicaltrials.gov/study/NCT06459869>, <https://clinicaltrials.gov/study/NCT03852511>, <https://clinicaltrials.gov/study/NCT05165433> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oncolytic adenovirus (T-SIGn), given into a vein, carrying a transgene" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/> ;
  onco:targets <https://onco.cc/targets/cd40/> ;
  onco:companies <https://onco.cc/companies/akamis-bio/> ;
  onco:trials <https://onco.cc/trials/nct06459869/>, <https://onco.cc/trials/nct03852511/>, <https://onco.cc/trials/nct05165433/> .